Question 1

ARQT vs MRK: which stock scores better overall?

Accepted Answer

Based on Q·Score, Arcutis Biotherapeutics, Inc. (ARQT) scores 7/10 versus Merck & Company, Inc. (MRK) at 6.7/10. The Q·Score measures five dimensions: Quality, Value, Growth, Safety, and Momentum. For informational purposes only — not financial advice.

Question 2

Which has better revenue growth: ARQT or MRK?

Accepted Answer

Arcutis Biotherapeutics, Inc. (ARQT) scores higher on Growth (8.3/10 vs 6.2/10). Arcutis Biotherapeutics, Inc. reports revenue growth (81.5% YoY) while Merck & Company, Inc. reports (4.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Question 3

Is ARQT or MRK more attractively valued?

Accepted Answer

Arcutis Biotherapeutics, Inc. (ARQT) scores higher on Value (9.1/10 vs 7.2/10). ARQT trades at 19.4× P/E versus MRK at 11.5×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

Question 4

What do analysts say about ARQT vs MRK?

Accepted Answer

There are 8 analysts covering ARQT with a consensus price target of $34.75, and 27 analysts covering MRK with a consensus target of $129.74. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Question 5

Which is more profitable: ARQT or MRK?

Accepted Answer

Merck & Company, Inc. (MRK) scores higher on Quality (6.2/10 vs 2.6/10). Net profit margin: ARQT at -4.3%, MRK at 13.6%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Question 6

Which has stronger financial health: ARQT or MRK?

Accepted Answer

Arcutis Biotherapeutics, Inc. (ARQT) scores higher on Financial Health (8.2/10 vs 7/10). Market beta: ARQT at 1.77, MRK at 0.28. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

Question 7

What are the market caps of ARQT and MRK?

Accepted Answer

Arcutis Biotherapeutics, Inc. (ARQT) has a market capitalisation of $2.9B, while Merck & Company, Inc. (MRK) has a market cap of $277.0B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Question 8

Do ARQT or MRK pay dividends?

Accepted Answer

ARQT does not currently pay a dividend, while MRK pays a dividend yield of 3.03%. Dividend yields fluctuate with share price and company payout decisions.

Arcutis Biotherapeutics, Inc. vs Merck & Company, Inc. — Stock Comparison

Q·Score Breakdown

Analyst Consensus

Fundamentals